Resources from the same session
Proffered Paper 2 – Gynaecological cancers - Invited Discussant 992O and LBA61
Presenter: Jonathan Ledermann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Presentation
Webcast
Lenvatinib (LEN) and Pembrolizumab (PEMBRO) in Advanced Endometrial Cancer (EC)
Presenter: Vicky Makker
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
FORWARD I (GOG 3011): A Phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
Presenter: Kathleen Moore
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Presentation
Webcast
Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
Presenter: Robert Naumann
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Presentation
Webcast
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian or Peritoneal Cancer
Presenter: David Gershenson
Session: Proffered Paper 2 – Gynaecological cancers
Resources:
Abstract
Presentation
Webcast